UnitedHealth Group Inc (NYSE:UNH) Shares Sold by Letko Brosseau & Associates Inc.

Letko Brosseau & Associates Inc. reduced its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 17.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,850 shares of the healthcare conglomerate’s stock after selling 400 shares during the quarter. Letko Brosseau & Associates Inc.’s holdings in UnitedHealth Group were worth $451,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Eastern Bank increased its position in shares of UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock valued at $16,858,000 after acquiring an additional 1,375 shares during the last quarter. Enterprise Bank & Trust Co acquired a new stake in shares of UnitedHealth Group during the first quarter valued at about $3,785,000. Private Advisors LLC increased its position in shares of UnitedHealth Group by 57.9% during the first quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after acquiring an additional 2,385 shares during the last quarter. Capital Investment Advisors LLC increased its position in shares of UnitedHealth Group by 26.2% during the second quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after acquiring an additional 1,323 shares during the last quarter. Finally, Calton & Associates Inc. increased its position in shares of UnitedHealth Group by 22.7% during the second quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock valued at $506,000 after acquiring an additional 384 shares during the last quarter. Hedge funds and other institutional investors own 85.65% of the company’s stock.

In related news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the transaction, the director now owns 187,663 shares in the company, valued at $45,412,569.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the completion of the transaction, the director now owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. Insiders sold 37,000 shares of company stock valued at $9,195,620 in the last quarter. 0.87% of the stock is owned by insiders.

Shares of UNH stock traded up $0.45 during trading on Thursday, reaching $243.65. The company’s stock had a trading volume of 136,793 shares, compared to its average volume of 3,513,135. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The firm has a market cap of $230.48 billion, a P/E ratio of 18.85, a price-to-earnings-growth ratio of 1.30 and a beta of 0.61. The company has a 50-day simple moving average of $251.31. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.14 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Inc will post 14.82 EPS for the current fiscal year.

A number of brokerages have weighed in on UNH. Bank of America reiterated a “buy” rating and set a $290.00 price target (down from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. ValuEngine cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, April 18th. SunTrust Banks dropped their price target on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research report on Wednesday, April 17th. They noted that the move was a valuation call. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research report on Friday, July 12th. Finally, Oppenheimer set a $312.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have issued a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: How Does the Quiet Period Work?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.